跳至主要内容
临床试验/NCT06235320
NCT06235320尚未招募不适用

Paracetamol Impact Study: Prostaglandin Synthesis and Blood Pressure Effects (PIS-PaB)

Charite University, Berlin, Germany0 个研究点目标入组 72 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
72
主要终点
Prostanoid levels

研究概览

简要总结

This research program aims to investigate the influence of paracetamol on blood pressure and the cyclooxygenase (COX) - prostaglandine (PG) pathway in patients with pain. Through an observational pilot study, we will use advanced LC/ESI-MS/MS methodology to analyze the COX-OG pathway in plasma and urine. The study will assess the effects of paracetamol compared to ibuprofen, considering different types of pain. The primary focus is to understand the changes in blood pressure and the COX-PG pathway upon initiation or discontinuation of paracetamol, with safety analysis as a secondary consideration.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Headache and orosurgical patients treated at the respective charite outpatient clinic.
  • Age 18 years or older
  • Able to consent
  • Patients with migraine type headache treated with paracetamol or ibuprofen within the last 12 hours or not treated with paracetamol or ibuprofen within the last 48 hours
  • Patients treated with with paracetamol or ibuprofen undergoing orosurgery for wisedome tooth extraction

排除标准

  • Pregnancy
  • Arterial hypertension
  • Use of beta blockers
  • Use of COX inhibitors other than paracetamol or ibuprofen, including low-dose acetylsalicylic acid
  • Stable prophylactic therapy of migraine for less than 3 weeks
  • Use of tryptans in the last two days (Frovatriptane in the last 6 days)
  • Oral surgery patients using paracetamol or ibuprofen in the last 24 hours
  • Known allergy to paracetamol or ibuprofen

结局指标

主要结局

Prostanoid levels

时间窗: just before treatment and 24 hours after treatment with paracetamol or ibuprofen

A comprehensive lipidomic analysis measuring the levels of prostanoids in plasma and spot urine samples using liquid chromatography tandem mass spectrometry (LC/ESI-MS/MS) technology in all participants.

次要结局

  • Blood pressure(just before treatment and 24 hours after treatment with paracetamol or ibuprofen)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Engi Algharably

Dr.

Charite University, Berlin, Germany

相似试验

已完成
4 期
PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) StudyBlood Pressure
NCT01997112University of Edinburgh100
进行中(未招募)
1 期
PAracetamol Treatment in Hypertension: effect on Blood Pressure (PATH-BP) StudyMedDRA version: 14.1 Level: PT Classification code 10005729 Term: Blood pressure ambulatory System Organ Class: 10022891 - InvestigationsMedDRA version: 14.1 Level: LLT Classification code 10020775 Term: Hypertension arterial System Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1 Level: PT Classification code 10005756 Term: Blood pressure systolic System Organ Class: 10022891 - InvestigationsMedDRA version: 14.1 Level: PT Classification code 10020772 Term: Hypertension System Organ Class: 10047065 - Vascular disordersMedDRA version: 14.1 Level: PT Classification code 10005735 Term: Blood pressure diastolic System Organ Class: 10022891 - InvestigationsMedDRA version: 14.1 Level: LLT Classification code 10033762 Term: Paracetamol System Organ Class: 10022891 - InvestigationsMedDRA version: 14.1 Level: PT Classification code 10005727 Term: Blood pressure System Organ Class: 10022891 - InvestigationsMedDRA version: 14.1 Level: PT Classification code 10015488 Term: Essential hypertension System Organ Class: 10047065 - Vascular disordersHypertension
EUCTR2013-003204-40-GBniversity of Edinburgh110
已完成
4 期
Drug Interaction Between Paracetamol and WarfarinStrokeAtrial FibrillationPulmonary EmbolismDeep Venous ThrombosisAntiphospholipid Syndrome
NCT01104337Hopital Lariboisière45
已完成
不适用
Paracetamol Metabolism After Liver SurgeryLiver ResectionParacetamol Administration
NCT01770041University of Edinburgh42
招募中
不适用
Hemodynamic Impact of the Administration of PAracetamol in Patients Hospitalized in the Intensive Resuscitation Medicine Department [PAREA]Intensive Care Unit Syndrome
NCT06430697Centre Hospitalier Universitaire de Nice200